GenVec Inc (GNVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

GenVec Inc (GenVec) focuses on the research and development of gene-based medicine. It develops therapeutics and vaccines using its proprietary adenovector gene delivery platform. The companys lead product, CGF166 is licensed to Novartis Institutes for BioMedical Research,Inc. and is in Phase I/II for the treatment of hearing loss. Its therapeutics portfolio includes novel drugs for Herpes Simplex virus and cancer. The company develops vaccines for respiratory syncytial virus (RSV), malaria and enterovirus. GenVec is developing vaccines against foot-and-mouth disease (FMD) in cattle. The company also collaborates with leading companies such as Novartis AG, and Merial Limited and with the US government to support a portfolio of product programs which are focused on the prevention and treatment of several human and animal health concerns. GenVec is head quartered in Maryland, the US.

GenVec Inc (GNVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GenVec Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GenVec Inc, Medical Devices Deals, 2011 to YTD 2017 9
GenVec Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GenVec Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
GenVec Enters into Agreement with Washington University in St. Louis 11
GenVec Enters into Agreement with Washington University at St. Louis 11
GenVec Enters into Research Agreement with LMIV 12
GenVec Enters into Co-Development Agreement with TheraBiologics 13
GenVec Enters Into Research And Development Agreement With US Naval Medical Research Center 14
Licensing Agreements 14
GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 14
GenVec Extends Licensing And Research Agreement With Novartis 15
Equity Offering 16
GenVec to Raise USD5 Million in Private Placement of Shares and Warrants 16
GenVec Completes Private Placement Of Shares For US$9 Million 17
Acquisition 18
Intrexon to Acquire GenVec 18
GenVec Inc - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 04, 2016: GenVec Reports Third Quarter 2016 Financial Results 24
Aug 05, 2016: GenVec Reports Second Quarter 2016 Financial Results 26
May 12, 2016: GenVec Reports First Quarter 2016 Financial Results 28
Mar 09, 2016: GenVec Reports Fourth Quarter and 2015 Year-End Financial Results 29
Other Significant Developments 31
Jan 20, 2016: GenVec Provides Investor Update 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables


GenVec Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GenVec Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GenVec Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GenVec Inc, Deals By Therapy Area, 2011 to YTD 2017 8
GenVec Inc, Medical Devices Deals, 2011 to YTD 2017 9
GenVec Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GenVec Enters into Agreement with Washington University in St. Louis 11
GenVec Enters into Agreement with Washington University at St. Louis 11
GenVec Enters into Research Agreement with LMIV 12
GenVec Enters into Co-Development Agreement with TheraBiologics 13
GenVec Enters Into Research And Development Agreement With US Naval Medical Research Center 14
GenVec Enters Into Licensing Agreement With Merial For Vaccine Technology 14
GenVec Extends Licensing And Research Agreement With Novartis 15
GenVec to Raise USD5 Million in Private Placement of Shares and Warrants 16
GenVec Completes Private Placement Of Shares For US$9 Million 17
Intrexon to Acquire GenVec 18
GenVec Inc, Key Competitors 21
GenVec Inc, Key Employees 22

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review

GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines GenVec, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review

GenVec Inc (GNVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available